Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_assertion type Assertion NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_head.
- NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_assertion description "[The Mdm2 inhibitor nutlin-3 was evaluated alone and in combination with cisplatin in a panel of germ cell tumour (GCT)-derived cell lines (embryonal carcinomas, being the nonseminomatous stem-cell component) with wild-type (NT2 and 2102EP cells) and mutant (NCCIT cells) p53 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_provenance.
- NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_assertion evidence source_evidence_literature NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_provenance.
- NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_assertion SIO_000772 19560254 NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_provenance.
- NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_assertion wasDerivedFrom befree-20150227 NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_provenance.
- NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_assertion wasGeneratedBy ECO_0000203 NP550805.RAEKIrP-Mq9TV8CE2-TcieVZgidB1D5HQ5OcVjuFaez38130_provenance.